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Either metastatic or primary squamous cell carcinoma in the gastrointestinal tract is extremely rare, with very few
cases reported in the literature. In this paper, we report a case in which the patient presented with dysphagia
during the course of radiotherapy for recurrent lung cancer in a mediastinal lymph node. Although the dysphagia
mimicked radiation esophagitis, the ultimate cause proved to be gastric and duodenal metastases from primary
lung squamous cell carcinoma. Taking into account the value of identification of metastatic or primary SCC in the
stomach and duodenum on the prognosis and treatment options, it is imperative that the correct diagnosis be
established. This report is followed by a discussion of the differential diagnosis between metastatic and primary
squamous cell carcinoma in the stomach and duodenum.
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Either metastatic or primary squamous cell carcinoma
(SCC) in the gastrointestinal tract is extremely rare, with
very few cases reported in the literature. The gastro-
intestinal tract has rarely been reported as a metastatic site
of various tumors, such as lung cancer, breast cancer,
hepatocellular carcinoma, melanoma, testicular seminoma,
choriocarcinoma, Merkel cell carcinoma, malignant fibrous
histiocytoma and others [1-4]. Most occurrences of meta-
static SCC involving the gastrointestinal tract originate
from lung primary tumors, but these occurrences remain
extremely rare, with very few cases of stomach or duo-
denal involvement reported in the literature [5,6].
The incidence of primary SCC of the stomach or
duodenum is also very low. It is estimated that the
worldwide incidence of primary SCC of the stomach is
0.04% to 0.07% [7,8]. Fewer than ten cases of primary
SCC of the duodenum have been noted [9]. In this report,
we present an unusual case of gastric and duodenal metas-
tases from primary lung SCC with a discussion of the
differential diagnosis between metastatic and primary SCC
in the stomach and duodenum.* Correspondence: sunxiaonan@hotmail.com
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A 54-year-old man was referred to our hospital because of
a 1-month history of cough. He had smoked one pack of
cigarettes per day for the past 20 years. A mass shadow in
the hilum of the right lung with an enlarged subcarinal
lymph node was found by contrast-enhanced computed
tomography (CT) of the chest. A bronchoscopic biopsy
yielded the diagnosis of SCC. After metastatic workup
with abdominal ultrasonography, magnetic resonance im-
aging of the brain and bone scan, the patient was staged
with T3N1M0 disease. Thereafter he underwent definitive
right-middle lobectomy, revealing well- to moderately dif-
ferentiated SCC and multiple lymph node metastases. He
received four cycles of adjuvant chemotherapy comprising
taxotere and cisplatin. Five months after his lobectomy,
an enlarged mediastinal lymph node was discovered on
a routine follow-up chest CT scan. Solitary lymph node
recurrence was diagnosed by coincidence circuit single-
photon emission CT assessment. The patient then under-
went a course of conformal external beam radiation to the
mediastinal lymph node at a dosage of 6,000 cGy in 30
fractions. He complained of dysphagia without melena or
hematemesis during the fourth week of radiotherapy,
which was attributed to radiation esophagitis. However,
the patient’s symptoms worsened despite symptomatic
treatment. A gastroduodenoscopy performed 10 days after
the completion of radiotherapy revealed a giant gastricThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Hu et al. World Journal of Surgical Oncology 2013, 11:204 Page 2 of 5
http://www.wjso.com/content/11/1/204ulcer in the greater curvature of the stomach with mucosal
edema and congestion as well as a huge cauliflower-like
mass in the descending part of the duodenum (Figure 1).
Biopsies of both lesions revealed SCC. On histopatho-
logical examination, hematoxylin and eosin–stained sec-
tions of gastric and duodenal biopsies revealed typical
SCC and large, eosinophilic cells with distinct cell borders
growing beneath the normal gastric and duodenal mucosa
(Figure 2). Keratinization, formation of small horn pearls
and malignant squamous cells in capillaries were also
observed. The morphology of the gastric and duodenal
lesions is similar to that of primary tumor of the lung. To
confirm the metastatic nature of the lesions, additional
immunohistochemical staining analyses of the duodenal
lesion were performed. These showed the lesion to stain
focally positive for cytokeratin 7 (CK7) and negative for
cytokeratin 20 (CK20) and thyroid transcription factor 1
(TTF-1), a staining pattern identical to that of the patient’s
primary lung SCC (Figure 3). The patient refused further
medical interventions and died of progressive disease 2
months later.Figure 1 Gastrointestinal tract metastases revealed by
gastroduodenoscopy. (A) A giant gastric ulcer in the greater
curvature of body is shown. (B) A huge cauliflower-like mass in the
descending part of duodenum is shown.
Figure 2 Histopathological views of gastric (A) and duodenal (B)
specimens showing squamous cell carcinoma with morphology
similar to that of the primary tumor in the lung (C).Discussion
Because of the absence of continuity between the gastric
and duodenal metastatic lesions, our present case report
is probably the first to describe gastric and duodenal
metastases from primary lung SCC. Taking into account
Figure 3 Focal positive staining to cytokeratin 7 of the duodenal lesion (A) and the primary of the lung (B).
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the stomach and duodenum on the prognosis and treat-
ment options, it is imperative that the correct diagnosis be
established. Usually, the visual diagnosis followed by tissue
diagnosis of the tumor is enough to establish the diagnosis
of SCC. However, it is rarely possible to differentiate meta-
static SCC from primary SCC involving the stomach and
duodenum based on symptoms and imaging findings,
because the major manifestations are the same. A docu-
mented history of SCC in other primary sites lends weight
to the diagnosis of metastasis, especially in patients with
diffuse metastases involving other organs. In this case,recurrence in the mediastinal lymph node and involve-
ment of both stomach and duodenum were highly sug-
gestive of metastatic rather than primary lesions. However,
it could be argued that a history of malignancy does not
necessarily imply that the new lesions are metastatic in na-
ture. An early-stage primary malignancy followed by new
ostensibly metastatic lesions after a relatively long interval
will make the differential diagnosis of metastasis versus
new primary tumor difficult. More importantly, the
diagnosis of metastatic tumor to gastrointestinal tract is
challenging on the rare occasions when it represents the
first and only metastatic site. It would be even more
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presents prior to the detection of the primary site.
Histological examination is critical as the most valuable
way to differentiate metastatic from primary tumors in-
volving the gastrointestinal tract. The differences in the
pathogenensis of metastatic or primary SCC in the gastro-
intestinal tract are also helpful to the differential diagnosis.
The gastrointestinal tract may be metastatically involved
by direct invasion, intraperitoneal dissemination and/or
lymphatic or hematogenous cancer spread. The pathogen-
esis of SCC in the stomach and duodenum has not been
well-elucidated. Several theories regarding the origin of
SCC in the stomach and duodenum have been proposed,
including nests of ectopic squamous cells, the prolifera-
tion of uncommitted mucosal basal cells into squamous
cells, squamous metaplasia secondary to chronic muco-
sal damage, squamous differentiation in a preexisting
adenocarcinonma and multipotent stem cells in the gas-
trointestinal mucosa [7,10,11]. Endoscopically, nearly all
the meatastatic cases present as submucosal tumors
with bridging folds and small ulcerations at the top,
termed volcano-like ulcers [5,12]. The morphologic
finding at low magnification of inverted tumor cell
growth (that is, with the tumor growth mainly involving
the serosal surface and perivisceral adipose tissue with
or without ulceration of the mucosa) often suggests a
metastatic tumor [13]. Unfortunately, these features can
be obscured by biopsy artefact and will disappear as the
tumor progresses.
Patients with gastrointestinal metastases are often asymp-
tomatic. Less frequently, these metastases can cause various
symptoms such as gastrointestinal perforation, obstruction
and/or hemorrhage. These nonspecific symptoms may be
misinterpreted as indefinite complaints or as a side effect
of treatment. For our patient, his complaint of dysphagia
was transiently misdiagnosed as radiation-related esopha-
gitis. Therefore, preemptive endoscopic examinations and
careful biopsies are recommended in symptomatic pa-
tients. The presence of misplaced squamous cell nests or
squamous metaplasia in the mucosa adjacent to the
infiltrative tumor growth is highly suggestive of a
primary SCC. However, in most of the reported cases
of primary gastric SCC, precursor lesions were not
demonstrated [8].
Immunohistochemistry may also be useful in reaching
the correct diagnosis. Over the past decade, expression
levels of CK7, CK20 and TTF-1 have been widely used to
distinguish pulmonary from gastrointestinal carcinomas,
especially when evaluated as a panel of markers [14].
However, these markers are mainly used to discriminate
adenocarcinoma or carcinoid tumors from different sites
and have limited value in the differential diagnosis of SCC.
Kanthan et al. adopted CK5, p63 and p16 as immunohis-
tochemical markers to confirm the diagnosis of SCC ofthe cervix metastatic to the duodenum [15]. Strikingly,
Gevaert et al. studied the expression profiles of a series
human epithelial cancers and their metastases by micro-
array technology and concluded that SCCs do not reflect
their primary tissue expression profile [16]. Huang et al.
performed immunohistochemical staining to compare
the expression pattern of the epithelial-mesenchymal
transition markers between primary SCC of the hypo-
pharynx and a metastatic lesion of the duodenum. Im-
pressively, dissociation of E-cadherin in cellular junctions
and nuclear expression of Snail were detected in the
primary tumor sample; in contrast, restoration of mem-
branous E-cadherin and disappearance of nuclear Snail ex-
pression were demonstrated in the duodenal metastatic
sample [17]. Their result may partially explain the unusual
metastasis from the metastatic mechanisms, which await
further verification.
Conclusions
The prevalence of SCC of the stomach and/or duode-
num is very low. The clinician should be aware of the
possibilities of either metastatic or primary involvement
of the stomach and duodenum with SCC. Distinguishing
between the two requires extensive evaluation, including
the patient’s clinical history, histological examination, im-
munohistochemical staining and possibly microarray data.
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